Medtronic PLC
$ 96.52
-0.04%
26 Dec - close price
- Market Cap 123,798,102,000 USD
- Current Price $ 96.52
- High / Low $ 96.75 / 96.01
- Stock P/E 26.16
- Book Value 37.95
- EPS 3.69
- Next Earning Report 2026-02-17
- Dividend Per Share $2.82
- Dividend Yield 2.92 %
- Next Dividend Date 2026-01-16
- ROA 0.05 %
- ROE 0.10 %
- 52 Week High 105.55
- 52 Week Low 76.87
About
Medtronic PLC is a premier global medical technology leader based in Fridley, Minnesota, dedicated to advancing healthcare through the development and commercialization of innovative medical devices and therapies in key areas such as cardiovascular care, diabetes management, and neuromodulation. The company prioritizes research and development, significantly investing in creating advanced solutions that improve patient outcomes and quality of life. With a strong focus on sustainability and a commitment to delivering value-driven healthcare, Medtronic is strategically positioned to tackle the evolving challenges in the medical device sector, reinforcing its vital role in shaping the future of healthcare.
Analyst Target Price
$110.97
Quarterly Earnings
| Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | Jul 2023 | Apr 2023 | Jan 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-18 | 2025-08-19 | 2025-05-21 | 2025-02-18 | 2024-11-19 | 2024-08-20 | 2024-05-23 | 2024-02-20 | 2023-11-21 | 2023-08-22 | 2023-05-25 | 2023-02-21 |
| Reported EPS | 1.36 | 1.26 | 1.62 | 1.39 | 1.26 | 1.23 | 1.46 | 1.3 | 1.25 | 1.2 | 1.57 | 1.3 |
| Estimated EPS | 1.31 | 1.23 | 1.58 | 1.36 | 1.25 | 1.2 | 1.45 | 1.26 | 1.18 | 1.11 | 1.56 | 1.27 |
| Surprise | 0.05 | 0.03 | 0.04 | 0.03 | 0.01 | 0.03 | 0.01 | 0.04 | 0.07 | 0.09 | 0.01 | 0.03 |
| Surprise Percentage | 3.8168% | 2.439% | 2.5316% | 2.2059% | 0.8% | 2.5% | 0.6897% | 3.1746% | 5.9322% | 8.1081% | 0.641% | 2.3622% |
Next Quarterly Earnings
| Jan 2026 | |
|---|---|
| Reported Date | 2026-02-17 |
| Fiscal Date Ending | 2026-01-31 |
| Estimated EPS | 1.33 |
| Currency | USD |
Previous Dividend Records
| Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-01-16 | 2025-10-17 | 2025-07-11 | 2025-04-11 | 2025-01-10 | 2024-10-11 | 2024-07-12 | 2024-04-12 | 2024-01-12 | 2023-10-13 |
| Amount | $0.71 | $0.71 | $0.71 | $0.7 | $0.7 | $0.7 | $0.7 | $0.69 | $0.69 | $0.69 |
Next Dividend Records
| Dividend per share (year): | $2.82 |
| Dividend Yield | 2.92% |
| Next Dividend Date | 2026-01-16 |
| Ex-Dividend Date | 2025-12-26 |
Recent News: MDT
2025-12-29 09:52:32
Ethic Inc. has reduced its stake in Medtronic PLC (NYSE:MDT) by 7.5% in the third quarter, selling 11,006 shares and retaining 135,412 shares valued at approximately $12.9 million. This adjustment comes as Medtronic exceeded Q3 earnings expectations, reporting an EPS of $1.36 against a $1.31 consensus, and set its FY2026 EPS guidance between $5.620 and $5.660. The company also announced a quarterly dividend of $0.71 per share with a 2.9% yield.
2025-12-28 21:38:28
This article provides investors with key updates on Medtronic (MDT) ahead of Monday's market open, focusing on its recent stock performance, upcoming dividend schedule, and significant catalysts like the MiniMed IPO and Hugo robotic surgery FDA clearance. It also touches on analyst forecasts and regulatory news impacting the medical technology giant. The overall sentiment suggests a constructive market backdrop for Medtronic, driven by strategic portfolio moves and growth drivers in cardiovascular and robotics.
2025-12-28 09:36:34
Columbus Macro LLC increased its stake in Medtronic PLC (NYSE:MDT) by 19.2% in the third quarter, bringing their total holdings to 85,748 shares valued at $8.17 million. Medtronic recently surpassed earnings expectations with $1.36 EPS and $8.96B revenue, announced a quarterly dividend of $0.71, and boasts a consensus "Moderate Buy" rating from analysts. The medical technology company's stock currently trades at $96.52 with a market capitalization of $123.7 billion.
2025-12-28 08:08:41
This article outlines five key healthcare themes that investors should monitor in 2026, following a period where healthcare stocks aligned with broader market performance after two years of underperformance. The growing weight-loss market, particularly with the launches of GLP-1 pills from Eli Lilly and Novo Nordisk, is highlighted as a significant transformative factor.
2025-12-27 21:35:41
Medtronic (NYSE: MDT) is heading into the weekend with investors considering its recently passed dividend record date, the planned MiniMed IPO to separate its diabetes business, and strong cardiovascular momentum. The stock closed Friday at $96.52, with thin trading volumes typical for the year-end "Santa rally" period. Over the weekend and leading into next week's trading, investors will be focused on MiniMed IPO developments, upcoming macro catalysts like Federal Reserve minutes, and Medtronic's Q3 FY26 earnings report expected around February 17, 2026.
2025-12-27 11:50:00
Greenup Street Wealth Management LLC has acquired 13,709 new shares of Medtronic PLC (NYSE:MDT) in the third quarter, valuing the stake at approximately $1.306 million. Medtronic exceeded quarterly expectations with $1.36 EPS and $8.96 billion in revenue, setting FY2026 guidance between $5.620-$5.660 EPS,
